Connect
MJA
MJA

Avoiding common problems associated with intravenous fluid therapy

Carlos D Scheinkestel, Andrew K Hilton and Vincent A Pellegrino
Med J Aust 2009; 190 (12): 718.
Published online: 15 June 2009

In reply: Franke presents some well known problems associated with intravenous administration of large volumes of 0.9% NaCl, particularly its relatively slow elimination (as compared with Hartmann’s solution), and hyperchloraemic acidosis.1 In isolation, we do not dispute these facts. However, 0.9% NaCl is not unique in having problems — no intravenous fluid therapy is without risk, especially when given in excessive volume, or when the composition is inappropriate for the patient’s needs.

  • Carlos D Scheinkestel
  • Andrew K Hilton
  • Vincent A Pellegrino

  • Intensive Care Unit, Alfred Hospital, Melbourne, VIC.

Correspondence: cd@scheinkestel.com.au

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.